Brantford, Canada

Alfredo Paul Ceccarelli

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009-2019

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alfredo Paul Ceccarelli

Introduction

Alfredo Paul Ceccarelli is a notable inventor based in Brantford, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important medicinal compounds. With a total of 5 patents to his name, Ceccarelli's work has had a meaningful impact on drug development.

Latest Patents

Ceccarelli's latest patents include innovative processes for the preparation of Apalutamide and Edoxaban. The patent for Apalutamide outlines processes that utilize an intermediate compound, providing improvements over existing methods. This invention is crucial for the efficient synthesis of Apalutamide, which is used in cancer treatment. His patent for Edoxaban details processes for preparing Edoxaban and its salts, along with various intermediates, enhancing the production methods for this anticoagulant medication.

Career Highlights

Throughout his career, Ceccarelli has worked with prominent companies in the pharmaceutical industry, including Apotex Inc. and Apotex Pharmachem Inc. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug formulation and production.

Collaborations

Ceccarelli has collaborated with talented individuals such as Prabhudas Bodhuri and Avedis Karadeolian. These partnerships have fostered a creative environment that has led to the development of innovative solutions in the pharmaceutical sector.

Conclusion

Alfredo Paul Ceccarelli's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…